DE2429040C2 - Steroid-Haptene, Verfahren zu deren Herstellung und deren Verwendung - Google Patents

Steroid-Haptene, Verfahren zu deren Herstellung und deren Verwendung

Info

Publication number
DE2429040C2
DE2429040C2 DE2429040A DE2429040A DE2429040C2 DE 2429040 C2 DE2429040 C2 DE 2429040C2 DE 2429040 A DE2429040 A DE 2429040A DE 2429040 A DE2429040 A DE 2429040A DE 2429040 C2 DE2429040 C2 DE 2429040C2
Authority
DE
Germany
Prior art keywords
general formula
compound
group
acid
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2429040A
Other languages
German (de)
English (en)
Other versions
DE2429040A1 (de
Inventor
André Noisy-le-Sec Pierdet
Vesperto Maisons-Alfort Torelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE2429040A1 publication Critical patent/DE2429040A1/de
Application granted granted Critical
Publication of DE2429040C2 publication Critical patent/DE2429040C2/de
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/823Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2429040A 1973-06-18 1974-06-18 Steroid-Haptene, Verfahren zu deren Herstellung und deren Verwendung Expired DE2429040C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7322114A FR2235949B1 (US07902200-20110308-C00004.png) 1973-06-18 1973-06-18

Publications (2)

Publication Number Publication Date
DE2429040A1 DE2429040A1 (de) 1975-01-09
DE2429040C2 true DE2429040C2 (de) 1985-10-31

Family

ID=9121104

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2429040A Expired DE2429040C2 (de) 1973-06-18 1974-06-18 Steroid-Haptene, Verfahren zu deren Herstellung und deren Verwendung

Country Status (16)

Country Link
US (1) US3922292A (US07902200-20110308-C00004.png)
JP (4) JPS5827280B2 (US07902200-20110308-C00004.png)
AT (1) AT343295B (US07902200-20110308-C00004.png)
BE (1) BE816457A (US07902200-20110308-C00004.png)
BR (1) BR7404979D0 (US07902200-20110308-C00004.png)
CA (1) CA1032927A (US07902200-20110308-C00004.png)
DE (1) DE2429040C2 (US07902200-20110308-C00004.png)
DK (1) DK322274A (US07902200-20110308-C00004.png)
ES (3) ES427318A1 (US07902200-20110308-C00004.png)
FR (1) FR2235949B1 (US07902200-20110308-C00004.png)
GB (2) GB1478356A (US07902200-20110308-C00004.png)
IE (1) IE41524B1 (US07902200-20110308-C00004.png)
LU (1) LU70329A1 (US07902200-20110308-C00004.png)
NL (1) NL7408041A (US07902200-20110308-C00004.png)
SE (1) SE402461B (US07902200-20110308-C00004.png)
ZA (1) ZA743841B (US07902200-20110308-C00004.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2277821A1 (fr) * 1974-07-10 1976-02-06 Roussel Uclaf Nouveaux haptenes derives de la progesterone, leur procede de preparation et leur application a la fabrication d'antigenes
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377417A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides substitues en 11b, ainsi que leur procede de preparation
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3572177D1 (de) 1984-10-19 1989-09-14 Nihon Mediphysics Co Ltd Imunoassay for estriol-3-sulfate
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
ATE162797T1 (de) * 1990-08-14 1998-02-15 Roussel Uclaf Neue 19-nor steroide, die eine amid tragende gruppe in der 11-beta-stelle haben, ihre herstellung, ihre verwendung als medikamente und pharmazeutische präparate davon
JPH059418U (ja) * 1991-07-12 1993-02-09 広島アルミニウム工業株式会社 電磁コンロ用発熱器
JPH07297707A (ja) * 1994-04-27 1995-11-10 Nec Corp 位相同期発振回路
NZ331975A (en) 1996-04-09 2000-12-22 Btg Int Ltd Use of 7 alpha-substituted steroids to treat neuropsychriatic disorders or enhance cognition
ATE482966T1 (de) 2004-07-27 2010-10-15 Sicor Inc Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211756A (en) * 1963-07-23 1965-10-12 Searle & Co 3-hydroxyimino-17alpha-(lower alkyl)-5alpha-androstan-17beta-ols and the optionally substituted 3-acyloxyimino and 3-alkoxyimino derivatives corresponding
DE1668682A1 (de) * 1967-03-14 1971-09-23 Searle & Co Gegebenenfalls in 17-Stellung alkylierte 11,13ss-Dialkylgona-1,3,5(10)-trien-3,17ss-diole und deren Ester

Also Published As

Publication number Publication date
DE2429040A1 (de) 1975-01-09
LU70329A1 (US07902200-20110308-C00004.png) 1975-03-06
ES448013A1 (es) 1977-07-01
JPS601200A (ja) 1985-01-07
GB1478357A (en) 1977-06-29
ATA504374A (de) 1977-09-15
BR7404979D0 (pt) 1975-01-21
JPS5934200B2 (ja) 1984-08-21
GB1478356A (en) 1977-06-29
FR2235949B1 (US07902200-20110308-C00004.png) 1978-03-17
JPS5036451A (US07902200-20110308-C00004.png) 1975-04-05
JPS5890597A (ja) 1983-05-30
ES427318A1 (es) 1976-09-16
AU7014874A (en) 1975-12-18
AT343295B (de) 1978-05-26
BE816457A (fr) 1974-12-17
ES448012A1 (es) 1977-07-01
JPS5827280B2 (ja) 1983-06-08
FR2235949A1 (US07902200-20110308-C00004.png) 1975-01-31
JPS6241719B2 (US07902200-20110308-C00004.png) 1987-09-04
CA1032927A (en) 1978-06-13
SE402461B (sv) 1978-07-03
ZA743841B (en) 1976-01-28
IE41524B1 (en) 1980-01-30
IE41524L (en) 1974-12-18
US3922292A (en) 1975-11-25
JPS5890600A (ja) 1983-05-30
SE7407108L (US07902200-20110308-C00004.png) 1974-12-19
NL7408041A (US07902200-20110308-C00004.png) 1974-12-20
DK322274A (US07902200-20110308-C00004.png) 1975-02-10
JPS5838440B2 (ja) 1983-08-23

Similar Documents

Publication Publication Date Title
DE2429040C2 (de) Steroid-Haptene, Verfahren zu deren Herstellung und deren Verwendung
NO132558B (US07902200-20110308-C00004.png)
DE1468035A1 (de) Verfahren zur Herstellung von 19-Alkylsteroiden
US3849402A (en) 19-oxygenated and 19-nor delta8(14)-steroid compounds
US2820030A (en) Certain 16, 17-oxido-steroids of the c21 series
US3342813A (en) Process for the preparation of butenolides derived from cyclopentano perhydro phenanthrenes
CH494213A (de) Verfahren zur Herstellung von Gonadienonen
DE2037402A1 (de) Verfahren zur Herstellung von 7 alpha Methylsteroiddenvaten
US3096350A (en) 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof
US3126374A (en) J-methyl progesterone derivatives
US3270007A (en) Process for cyclopentanophenanthrene compounds
US2780621A (en) Side chain degradation of 11-keto steroids
US4097477A (en) Steroid compounds and processes thereof
Oliveto et al. 11-Oxygenated Steroids. X. The Reduction of 21-Benzylidenepregnan-3α-ol-11, 20-dione with Various Metal Hydrides1
DE1468227C (de) Verfahren zur Herstellung von Delta hoch 4 - bzw. Delta hoch 5 -ungesättigten Steroiden der Androstan-, Pregnan- und Sapogeninreihe mit einer freien oder veresterten Hydroxygruppe in 19-Stellung
Balant et al. Investigations on steroids. XIX. Further Degradation Products of Strophanthidol
Johns et al. Steroidal Spirolactols (17→ 22)
US3219674A (en) 15-dehydro-16 methyl steroids and process for the production thereof
DE2222544C3 (de) Neue 16,17-Secoöstradi- und triene Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
US3463795A (en) Unsaturated cycloheptano perhydro phenantrenes and their preparation
US3423405A (en) Preparation of 1,3,5(10),9(11) steroids and novel intermediates thereof
JP2631472B2 (ja) ブラシノステロイド誘導体及びその製造法
US4058539A (en) 4,6,8(14)-Triene steroids
US2897197A (en) Preparation of 7,11-diketo-steroids
DE1668665C (de) Verfahren zur Herstellung von 13-Alky 1-gona-1,3,5( 10)-trienen. Ausscheidung aus: 1443123

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8380 Miscellaneous part iii

Free format text: IM PATENTANSPRUCH 1, ZEILE 46 IST DER WERT "10" IN "18" ZU AENDERN

8339 Ceased/non-payment of the annual fee